Cargando…

Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia

Triple negative breast cancer (TNBC) is a difficult to treat disease due to the absence of the three unique receptors estrogen, progesterone and herceptin-2 (HER-2). To improve the current therapy and overcome the resistance of TNBC, there is unmet need to develop an effective targeted therapy. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatiparti, Katyayani, Sau, Samaresh, Gawde, Kaustubh A., Iyer, Arun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877699/
https://www.ncbi.nlm.nih.gov/pubmed/29534020
http://dx.doi.org/10.3390/ijms19030838
_version_ 1783310752565690368
author Tatiparti, Katyayani
Sau, Samaresh
Gawde, Kaustubh A.
Iyer, Arun K.
author_facet Tatiparti, Katyayani
Sau, Samaresh
Gawde, Kaustubh A.
Iyer, Arun K.
author_sort Tatiparti, Katyayani
collection PubMed
description Triple negative breast cancer (TNBC) is a difficult to treat disease due to the absence of the three unique receptors estrogen, progesterone and herceptin-2 (HER-2). To improve the current therapy and overcome the resistance of TNBC, there is unmet need to develop an effective targeted therapy. In this regard, one of the logical and economical approaches is to develop a tumor hypoxia-targeting drug formulation platform for selective delivery of payload to the drug-resistant and invasive cell population of TNBC tumors. Toward this, we developed a Carbonic Anhydrase IX (CA IX) receptor targeting human serum albumin (HSA) carriers to deliver the potent anticancer drug, Paclitaxel (PTX). We used Acetazolamide (ATZ), a small molecule ligand of CA IX to selectively deliver HSA-PTX in TNBC cells. A novel method of synthesis involving copper free ‘click’ chemistry (Dibenzocyclooctyl, DBCO) moiety with an azide-labeled reaction partner, known as Strain-Promoted Alkyne Azide Cycloaddition (SPAAC) along with a desolvation method for PTX loading were used in the present study to arrive at the CA IX selective nano-carriers, HSA-PTX-ATZ. The anticancer effect of HSA-PTX-ATZ is higher compared to HSA, PTX and non-targeted HSA-PTX in MDA-MB-231 and MDA-MB-468 cells. The cell killing effect is associated with induction of early and late phases of apoptosis. Overall, our proof-of-concept study shows a promising avenue for hypoxia-targeted drug delivery that can be adapted to several types of cancers.
format Online
Article
Text
id pubmed-5877699
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58776992018-04-09 Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia Tatiparti, Katyayani Sau, Samaresh Gawde, Kaustubh A. Iyer, Arun K. Int J Mol Sci Article Triple negative breast cancer (TNBC) is a difficult to treat disease due to the absence of the three unique receptors estrogen, progesterone and herceptin-2 (HER-2). To improve the current therapy and overcome the resistance of TNBC, there is unmet need to develop an effective targeted therapy. In this regard, one of the logical and economical approaches is to develop a tumor hypoxia-targeting drug formulation platform for selective delivery of payload to the drug-resistant and invasive cell population of TNBC tumors. Toward this, we developed a Carbonic Anhydrase IX (CA IX) receptor targeting human serum albumin (HSA) carriers to deliver the potent anticancer drug, Paclitaxel (PTX). We used Acetazolamide (ATZ), a small molecule ligand of CA IX to selectively deliver HSA-PTX in TNBC cells. A novel method of synthesis involving copper free ‘click’ chemistry (Dibenzocyclooctyl, DBCO) moiety with an azide-labeled reaction partner, known as Strain-Promoted Alkyne Azide Cycloaddition (SPAAC) along with a desolvation method for PTX loading were used in the present study to arrive at the CA IX selective nano-carriers, HSA-PTX-ATZ. The anticancer effect of HSA-PTX-ATZ is higher compared to HSA, PTX and non-targeted HSA-PTX in MDA-MB-231 and MDA-MB-468 cells. The cell killing effect is associated with induction of early and late phases of apoptosis. Overall, our proof-of-concept study shows a promising avenue for hypoxia-targeted drug delivery that can be adapted to several types of cancers. MDPI 2018-03-13 /pmc/articles/PMC5877699/ /pubmed/29534020 http://dx.doi.org/10.3390/ijms19030838 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tatiparti, Katyayani
Sau, Samaresh
Gawde, Kaustubh A.
Iyer, Arun K.
Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title_full Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title_fullStr Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title_full_unstemmed Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title_short Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
title_sort copper-free ‘click’ chemistry-based synthesis and characterization of carbonic anhydrase-ix anchored albumin-paclitaxel nanoparticles for targeting tumor hypoxia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877699/
https://www.ncbi.nlm.nih.gov/pubmed/29534020
http://dx.doi.org/10.3390/ijms19030838
work_keys_str_mv AT tatipartikatyayani copperfreeclickchemistrybasedsynthesisandcharacterizationofcarbonicanhydraseixanchoredalbuminpaclitaxelnanoparticlesfortargetingtumorhypoxia
AT sausamaresh copperfreeclickchemistrybasedsynthesisandcharacterizationofcarbonicanhydraseixanchoredalbuminpaclitaxelnanoparticlesfortargetingtumorhypoxia
AT gawdekaustubha copperfreeclickchemistrybasedsynthesisandcharacterizationofcarbonicanhydraseixanchoredalbuminpaclitaxelnanoparticlesfortargetingtumorhypoxia
AT iyerarunk copperfreeclickchemistrybasedsynthesisandcharacterizationofcarbonicanhydraseixanchoredalbuminpaclitaxelnanoparticlesfortargetingtumorhypoxia